Literature DB >> 12237927

Characterization of 11 human sarcoma cell strains: evaluation of cytogenetics, tumorigenicity, metastasis, and production of angiogenic factors.

Mei Hu1, Garth L Nicolson, Jonathan C Trent, Dihua Yu, Lianglin Zhang, Aiqing Lang, Ann Killary, Lee M Ellis, Corazon D Bucana, Raphael E Pollock.   

Abstract

BACKGROUND: Human sarcomas have a propensity for aggressive local invasion and early pulmonary metastasis. Frequently, deaths are due to uncontrolled pulmonary metastases. The purpose of the current study was to evaluate cytogenetics, tumorigenicity, metastatic potential, and production of angiogenic factors in human sarcoma cell strains. A secondary purpose was to establish low passage cell strains for studying new therapeutic approaches.
METHODS: The authors established 11 cell strains from human sarcoma surgical specimens and characterized their in vitro tumor properties, including growth in soft agar, expression of angiogenic growth factors (vascular endothelial growth factor [VEGF] and basic-fibroblast growth factor [bFGF]), and cytogenetics.
RESULTS: All of the cell strains remained diploid. All exhibited the ability to grow in soft agar and expressed both VEGF as well as bFGF. In addition, 6 of the 11 established sarcoma cell strains were tumorigenic, 5 of which spontaneously metastasized to the lungs in nude mice. Four of the five cell strains that yielded lung metastases were derived from lung metastases in patients.
CONCLUSIONS: The 11 cell strains, which were derived from diverse sarcoma histologies, will provide a model for studying not only metastatic progression but also the in vitro and in vivo efficacy of new therapeutic modalities for human sarcomas. Copyright 2002 American Cancer Society.DOI 10.1002/cncr.10879

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12237927     DOI: 10.1002/cncr.10879

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Benign mesenchymal stromal cells in human sarcomas.

Authors:  Alexei Morozov; Robert J Downey; John Healey; Andre L Moreira; Emil Lou; Anna Franceschino; Yildirim Dogan; Roland Leung; Mark Edgar; Michael LaQuaglia; Robert G Maki; Malcolm A S Moore
Journal:  Clin Cancer Res       Date:  2010-12-01       Impact factor: 12.531

2.  Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients.

Authors:  Thomas K Kilvaer; Andrej Valkov; Sveinung W Sorbye; Eivind Smeland; Roy M Bremnes; Lill-Tove Busund; Tom Donnem
Journal:  J Transl Med       Date:  2011-07-06       Impact factor: 5.531

Review 3.  Three-Dimensional Patient-Derived In Vitro Sarcoma Models: Promising Tools for Improving Clinical Tumor Management.

Authors:  Manuela Gaebler; Alessandra Silvestri; Johannes Haybaeck; Peter Reichardt; Caitlin D Lowery; Louis F Stancato; Gabriele Zybarth; Christian R A Regenbrecht
Journal:  Front Oncol       Date:  2017-09-11       Impact factor: 6.244

4.  Comments on cultured human sarcoma cells.

Authors:  Joseph G Sinkovics
Journal:  Sarcoma       Date:  2003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.